Co-founder and COO
The impact funding and risk guarantee received from SAMRIDH has been instrumental for Blackfrog to raise commercial capital from financial institutions. This has enabled us to scale up our manufacturing capacity for Emvólio and cater to markets across India and overseas.
Co-founder and CEO
Sharing a common vision to strengthen India’s health system, USAID-supported SAMRIDH has enabled us to sustain existing operations and scale up the deployment of our AI-driven chest X-ray screening solution in rural and semi-urban hospital settings. SAMRIDH’s support is further helping us in unlocking new opportunities to raise capital and meet funding requirements for expansion across the healthcare sector in India and globally.
Founder & CEO
Cardiac Design Labs
SAMRIDH has been a key partner in our efforts to scale-up Padma Vitals across the length and breadth of India, particularly to enhance its access for vulnerable communities. The support received through the initiative enabled us in timely procurement of Padma Vitals devices and improvement in the product outreach. This collaboration has set us on the path to achieve financial sustainability in the long run.
Head of Service Sales
Wipro GE Healthcare Pvt. Ltd.
We were able to expand our capacity-building initiative with help from SAMRIDH. SAMRIDH’s initial commitment to support operational expenses for capacity-building trainings of healthcare workers enabled us to secure a work order to skill the youth of the country under various schemes related to COVID-19 training. With this fresh impetus to our initiative, we will continue to deliver transformative impact as we prepare healthcare systems to respond effectively to COVID-19 and other public health emergencies.
Collateral Medical Pvt. Ltd
During the peak of the pandemic, the funding and advisory services we received from SAMRIDH enabled us to manage our cash flow more effectively, cut operating expenses, and use savings as cash collateral to secure a working capital term loan from an impact investment firm. The capital raised allowed us to accelerate the supply of oxygen concentrators to fulfil immediate orders and expand our offerings in the healthcare vertical.